International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women

CONCLUSION: Despite substantial evidence regarding safety, efficacy, and clinical use, access to testosterone therapy for the treatment of HSDD in women remains a significant unmet need.PMID:33792440 | DOI:10.1080/13697137.2021.1891773

Source: Climacteric - April 1, 2021 Category: Geriatrics Authors: Sharon J Parish James A Simon Susan R Davis Annamaria Giraldi Irwin Goldstein Sue W Goldstein Noel N Kim Sheryl A Kingsberg Abraham Morgentaler Rossella E Nappi Kwangsung Park Cynthia A Stuenkel Abdulmaged M Traish Linda Vignozzi Source Type: research